An investment update3 Aug 2023 14:21
Sareum Holdings PLC - Cambridge-based biotechnology company developing kinase inhibitors for autoimmune diseases and cancers - Agrees terms on equity prepayment facility of up to GBP5 million with RiverFort Global Opportunities PCC Ltd, as arranged by RiverFort Global Capital Ltd, with an initial deposit of GBP2 million. This is expected on August 4, net of associated costs.
Two further committed deposits of GBP300,000 each are due on the three month and six month anniversaries of the first deposit, as well as a fourth deposit on the six month anniversary of up to GBP1.4 million.
Riverfort Global Capital is a London-based firm, principally focused on investing in junior listed companies by way of debt or equity-linked debt investments